Sphingomyelinase inhibits in vitro Leydig cell function.

Activation of the immune system has profound effects on endocrine function which are mediated by cytokines including tumor necrosis factor-alpha (TNF alpha). In vitro, TNF alpha has been shown to directly inhibit Leydig cell testosterone (T) production, but the mechanism of this effect is still unclear. Recent studies using cultured human fibroblasts have shown that TNF alpha stimulates the activity of neutral sphingomyelinase (SMase) which hydrolyses sphingomyelin (SM) generating ceramide and changing membrane components including cholesterol. The cellular affects of increased SMase activity have been reproduced in vitro by the addition of exogenous SMase. In cultured fibroblasts, exogenous SMase decreases cholesterol synthesis. These findings led us to hypothesize that SMase might be important in the regulation of steroid hormone synthesis. To our knowledge, no previous studies have investigated this possibility. To test this hypothesis, rat Leydig cell enriched cultures were incubated in media containing SMase (0.1 to 100 mU/ml) or in control media. SMase significantly decreased basal and human chorionic gonadotropin (hCG) stimulated T production. SMase also decreased hCG binding and hCG stimulated adenosine 3':5'-cyclic monophosphate (cAMP). N-acetyl-sphingosine (0.1 to 10 microM), a water soluble ceramide, was used to determine whether or not the effects of SMase could be reproduced by ceramide addition. N-acetyl-sphingosine had only slight effects on basal T and cAMP, and no effect on hCG binding or hCG stimulated T or cAMP. These data suggest the metabolism of membrane sphingomyelin may be an important regulatory pathway in the control of Leydig cell function.

[1]  A. Rogol,et al.  Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. , 1995, Science.

[2]  J. Saez Leydig cells: endocrine, paracrine, and autocrine regulation. , 1994, Endocrine reviews.

[3]  Y. Hannun,et al.  Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. , 1994, The Journal of biological chemistry.

[4]  L. Sanz,et al.  Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. , 1994, The Journal of biological chemistry.

[5]  G. Ranges,et al.  Inhibition of ceramide pathway does not affect ability of TNF-alpha to activate nuclear factor-kappa B. , 1994, Journal of immunology.

[6]  Y. Hannun,et al.  Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. , 1994, The Journal of biological chemistry.

[7]  S. Chatterjee Neutral sphingomyelinase action stimulates signal transduction of tumor necrosis factor-alpha in the synthesis of cholesteryl esters in human fibroblasts. , 1994, The Journal of biological chemistry.

[8]  F. Field,et al.  Sphingomyelin content of intestinal cell membranes regulates cholesterol absorption. Evidence for pancreatic and intestinal cell sphingomyelinase activity. , 1992, The Biochemical journal.

[9]  H. Kanzaki,et al.  Cytokine modulation of progesterone and estradiol secretion in cultures of luteinized human granulosa cells. , 1992, The Journal of clinical endocrinology and metabolism.

[10]  W. Chang,et al.  Down-regulation of Leydig cell insulin-like growth factor-I gene expression by interleukin-1. , 1992, Endocrinology.

[11]  H. Imura,et al.  Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems , 1991, Clinical endocrinology.

[12]  T. van der Poll,et al.  Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. , 1990, The Journal of clinical endocrinology and metabolism.

[13]  R. Horton,et al.  Tumor necrosis factor and interleukin-1 stimulate testosterone secretion in adult male rat Leydig cells in vitro. , 1990, Journal of andrology.

[14]  B. Beutler,et al.  Hypothalamic action of cachectin to alter pituitary hormone release , 1989, Brain Research Bulletin.

[15]  G. Snyder,et al.  Cachectin alters anterior pituitary hormone release by a direct action in vitro. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Kawakami,et al.  Effects of Tumor Necrosis Factor-α/Cachectin on Thyroid Hormone Metabolism in Mice , 1988 .

[17]  N. Emoto,et al.  The effect of tumor necrosis factor/cachectin on follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells. , 1988, Biochemical and biophysical research communications.

[18]  J. Slotte,et al.  Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. , 1988, The Biochemical journal.

[19]  B. Beutler,et al.  Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. , 1988, Endocrine reviews.

[20]  K. Cantell,et al.  Human leukocyte interferon inhibits human chorionic gonadotropin stimulated testosterone production by porcine Leydig cells in culture. , 1985, Biochemical and biophysical research communications.

[21]  F. Haour,et al.  Regulation of gonadotropin receptors and steroidogenesis in cultured porcine Leydig cells. , 1982, Endocrinology.

[22]  R. Newman,et al.  The effect of macrophage conditioned media on Leydig cell function. , 1994, Annals of clinical and laboratory science.

[23]  A. Gupta,et al.  Plasma membrane sphingomyelin and the regulation of HMG-CoA reductase activity and cholesterol biosynthesis in cell cultures. , 1991, Journal of lipid research.

[24]  U. Stenman,et al.  Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. , 1991, Endocrinology.

[25]  S. Mccann,et al.  Role of monokines in control of anterior pituitary hormone release. , 1990, Advances in experimental medicine and biology.